TCL Archive NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants February 14, 1992
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant. April 16, 2004
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012
TCL Archive In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores June 12, 1981
